Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles D Howell

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Clinics in Liver Disease|October 5, 2002
Animal models of autoimmunityCharles D Howell
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 1, 2009
Racial disparities in liver transplantation for hepatitis B: to be or not to beCharles D Howell
Hepatology (Baltimore, Md.)|January 12, 2002
Oligoclonal expansion of T cell receptor V beta 2 and 3 cells in the livers of mice with graft-versus-host diseaseWeiran Chen, Charles D Howell
Clinics in Liver Disease|April 6, 2019
Rheumatologic Diseases and the LiverAgazi Gebreselassie, Farshad Aduli, Charles D Howell
Journal of Hepatology|December 19, 2012
Reply to: "Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling"Charles D Howell, Runyan Jin, Thomas C Dowling
Journal of the National Medical Association|December 30, 2008
Peripheral blood gene expression profile associated with sustained virologic response after peginterferon plus ribavirin therapy for chronic hepatitis-C genotype 1Chao Huang, Hegang Chen, William Cassidy, et al.
Expert Review of Gastroenterology & Hepatology|August 12, 2014
Association between interferon use and reduced metabolic and vascular complications among patients with hepatitis CViktor V Chirikov, Fadia T Shaya, Charles D Howell
Hepatology (Baltimore, Md.)|March 11, 2015
Contextual analysis of determinants of late diagnosis of hepatitis C virus infection in medicare patientsViktor V Chirikov, Fadia T Shaya, Charles D Howell
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 11, 2006
Risk factors for primary hepatocellular carcinoma in black and white Americans in 2000Lei Yu, Dana A Sloane, Chuanfa Guo, et al.
Hepatology (Baltimore, Md.)|June 9, 2004
Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1Lennox J Jeffers, William Cassidy, Charles D Howell, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Clinics in Liver Disease|October 5, 2002
Animal models of autoimmunityCharles D Howell
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 1, 2009
Racial disparities in liver transplantation for hepatitis B: to be or not to beCharles D Howell
Hepatology (Baltimore, Md.)|January 12, 2002
Oligoclonal expansion of T cell receptor V beta 2 and 3 cells in the livers of mice with graft-versus-host diseaseWeiran Chen, Charles D Howell
Clinics in Liver Disease|April 6, 2019
Rheumatologic Diseases and the LiverAgazi Gebreselassie, Farshad Aduli, Charles D Howell
Journal of Hepatology|December 19, 2012
Reply to: "Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling"Charles D Howell, Runyan Jin, Thomas C Dowling
Journal of the National Medical Association|December 30, 2008
Peripheral blood gene expression profile associated with sustained virologic response after peginterferon plus ribavirin therapy for chronic hepatitis-C genotype 1Chao Huang, Hegang Chen, William Cassidy, et al.
Expert Review of Gastroenterology & Hepatology|August 12, 2014
Association between interferon use and reduced metabolic and vascular complications among patients with hepatitis CViktor V Chirikov, Fadia T Shaya, Charles D Howell
Hepatology (Baltimore, Md.)|March 11, 2015
Contextual analysis of determinants of late diagnosis of hepatitis C virus infection in medicare patientsViktor V Chirikov, Fadia T Shaya, Charles D Howell
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 11, 2006
Risk factors for primary hepatocellular carcinoma in black and white Americans in 2000Lei Yu, Dana A Sloane, Chuanfa Guo, et al.
Hepatology (Baltimore, Md.)|June 9, 2004
Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1Lennox J Jeffers, William Cassidy, Charles D Howell, et al.
Pageof 5